Business Description
Genetec Corp
ISIN : JP3428000008
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.33 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.58 | |||||
Debt-to-EBITDA | 2.06 | |||||
Interest Coverage | 87.9 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.79 | |||||
Beneish M-Score | -2.61 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.6 | |||||
3-Year EBITDA Growth Rate | 36.3 | |||||
3-Year EPS without NRI Growth Rate | 32.4 | |||||
3-Year FCF Growth Rate | 6 | |||||
3-Year Book Growth Rate | 5.7 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.7 | |||||
9-Day RSI | 53.01 | |||||
14-Day RSI | 46.58 | |||||
6-1 Month Momentum % | -2.48 | |||||
12-1 Month Momentum % | 26.08 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.74 | |||||
Quick Ratio | 1.65 | |||||
Cash Ratio | 0.88 | |||||
Days Inventory | 17.37 | |||||
Days Sales Outstanding | 56.79 | |||||
Days Payable | 23.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.16 | |||||
Dividend Payout Ratio | 0.41 | |||||
3-Year Dividend Growth Rate | 74.9 | |||||
Forward Dividend Yield % | 3.33 | |||||
5-Year Yield-on-Cost % | 0.72 | |||||
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | 4.01 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 40.7 | |||||
Operating Margin % | 8.81 | |||||
Net Margin % | 5.8 | |||||
FCF Margin % | 6.93 | |||||
ROE % | 19.7 | |||||
ROA % | 9.57 | |||||
ROIC % | 16.15 | |||||
ROC (Joel Greenblatt) % | 87.24 | |||||
ROCE % | 23.7 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 15.33 | |||||
PE Ratio without NRI | 15.39 | |||||
Price-to-Owner-Earnings | 16.25 | |||||
PEG Ratio | 4.53 | |||||
PS Ratio | 0.89 | |||||
PB Ratio | 2.79 | |||||
Price-to-Tangible-Book | 4.84 | |||||
Price-to-Free-Cash-Flow | 12.87 | |||||
Price-to-Operating-Cash-Flow | 10.58 | |||||
EV-to-EBIT | 9.19 | |||||
EV-to-EBITDA | 9.19 | |||||
EV-to-Revenue | 0.81 | |||||
EV-to-FCF | 11.9 | |||||
Price-to-Graham-Number | 1.78 | |||||
Price-to-Net-Current-Asset-Value | 7.9 | |||||
Earnings Yield (Greenblatt) % | 10.89 | |||||
FCF Yield % | 7.89 | |||||
Forward Rate of Return (Yacktman) % | 5.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Genetec Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 7,147.976 | ||
EPS (TTM) (円) | 35.875 | ||
Beta | 3.2 | ||
Volatility % | 71.24 | ||
14-Day RSI | 46.58 | ||
14-Day ATR (円) | 18.451816 | ||
20-Day SMA (円) | 538.3 | ||
12-1 Month Momentum % | 26.08 | ||
52-Week Range (円) | 446 - 1500 | ||
Shares Outstanding (Mil) | 11.42 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Genetec Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Genetec Corp Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Genetec Corp Frequently Asked Questions
What is Genetec Corp(TSE:4492)'s stock price today?
When is next earnings date of Genetec Corp(TSE:4492)?
Does Genetec Corp(TSE:4492) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |